Discovery and development of covalent BTK inhibitors

被引：0
|
作者：
Chen, Wei [1 ]
机构：
[1] Pharmacyclics Inc, Sunnyvale, CA USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2015年 / 249卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
204
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Novel irreversible covalent BTK inhibitors discovered using DNA-encoded chemistry
    Guilinger, John P.
    Archana, Archna
    Augustin, Martin
    Bergmann, Andreas
    Centrella, Paolo A.
    Clark, Matthew A.
    Cuozzo, John W.
    Daether, Maike
    Guie, Marie-Aude
    Habeshian, Sevan
    Kiefersauer, Reiner
    Krapp, Stephan
    Lammens, Alfred
    Lercher, Lukas
    Liu, Julie
    Liu, Yanbin
    Maskos, Klaus
    Mrosek, Michael
    Pfluegler, Klaus
    Siegert, Markus
    Thomson, Heather A.
    Tian, Xia
    Zhang, Ying
    Makino, Debora L. Konz
    Keefe, Anthony . D.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 42
  • [42] Covalent inhibitors: An ambitious approach for the discovery of newer oncotherapeutics
    Cheke, Rameshwar S.
    Kharkar, Prashant S.
    [J]. DRUG DEVELOPMENT RESEARCH, 2024, 85 (01)
  • [43] Discovery of GDC-0853: A highly potent, selective, and non-covalent Btk inhibitor
    Young, Wendy
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [44] Discovery of pyrazolopyrimidine derivatives as potent BTK inhibitors with effective anticancer activity in MCL
    Ran, Fansheng
    Liu, Yang
    Liu, Meixia
    Zhang, Daoguang
    Wang, Peng
    Dong, Junze
    Tang, Wendi
    Zhao, Guisen
    [J]. BIOORGANIC CHEMISTRY, 2019, 89
  • [45] Discovery of 1-Amino-1H-imidazole-5-carboxamide Derivatives as Highly Selective, Covalent Bruton's Tyrosine Kinase (BTK) Inhibitors
    Ma, Chunhua
    Li, Qingyun
    Zhao, Minghao
    Fan, Goujie
    Zhao, Jie
    Zhang, Dandan
    Yang, Shouning
    Zhang, Shuting
    Gao, Dingding
    Mao, Longfei
    Zhu, Liang
    Li, Wei
    Xu, Guiqing
    Jiang, Yuqin
    Ding, Qingjie
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (21) : 16242 - 16270
  • [46] Discovery of orally active 1,4,5,6,8-pentaazaacenaphthylens as novel, selective, and potent covalent BTK inhibitors for the treatment of rheumatoid arthritis
    Fang, Xiaobao
    Liu, Chunxiao
    Zhang, Kun
    Yang, Wanping
    Wu, Zewen
    Shen, Shige
    Ma, Yule
    Lu, Xun
    Chen, Yadong
    Lu, Tao
    Hu, Qinghua
    Jiang, Yulei
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 246
  • [47] Btk inhibitors in atherosclerosis
    Lindner, Jonathan R.
    [J]. BLOOD, 2018, 131 (24) : 2601 - 2602
  • [48] Development and characterization of covalent kinase inhibitors
    Gray, Nathanael S.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [49] Recent advances in the development of covalent inhibitors
    Kim, Hyunsoo
    Hwang, Yoon Soo
    Kim, Mingi
    Park, Seung Bum
    [J]. RSC MEDICINAL CHEMISTRY, 2021, 12 (07): : 1037 - 1045
  • [50] Review of the development of BTK inhibitors in overcoming the clinical limitations of ibrutinib
    Ran, Fansheng
    Liu, Yun
    Wang, Chen
    Xu, Zhongyuan
    Zhang, Yanan
    Liu, Yang
    Zhao, Guisen
    Ling, Yong
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 229
12345